Feed aggregator
APPLOVIN INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of AppLovin Corporation - APP
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into AppLovin Corporation (NasdaqGS: APP). On February 26, 2025, analyst research reports highlighted that the Company was engaging in “Ad Fraud” and other dubious practices including reverse engineering and exploiting advertising data from Meta Platforms, and utilizing m
BAC Applauds Landmark Passage of Trigger Lead Ban
WASHINGTON--(BUSINESS WIRE)--The Broker Action Coalition (BAC) welcomes the passage of the Homebuyers Privacy Protection Act, bipartisan legislation that limits the sale of trigger leads. With the Senate passing the House version on August 2, the bill has officially cleared Congress and now heads to the President’s desk. The BAC urges President Trump to sign the bill into law without delay. The passage of this bill through Congress marks the culmination of a multi-year advocacy effort—driven by
RCKT Deadline: Rosen Law Firm Urges Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) Stockholders with Losses in Excess of $100K to Contact the Firm for Information About Their Rights
NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action lawsuit on behalf of purchasers of securities of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) between September 17, 2024 and May 26, 2025. Rocket Pharmaceuticals is a fully integrated, late-stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigat
